[{"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q3_USD":9213000.0,"RestrictedCash_0_Q3_USD":1729000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":39025000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":15115000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":11801000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":13697000.0,"ProfitLoss_3_Q3_USD":-50518000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":128000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":67000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_3_Q3_USD":143000000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":237750000.0,"RestrictedCashNoncurrent_0_Q3_USD":1729000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3485000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":231000.0,"PaymentsOfDividends_3_Q3_USD":0.0,"PaymentsForRepurchaseOfInitialPublicOffering_3_Q3_USD":2950000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q3_USD":-535000.0,"OperatingIncomeLoss_3_Q3_USD":-49495000.0,"OperatingIncomeLoss_1_Q3_USD":-19868000.0,"OperatingExpenses_3_Q3_USD":49495000.0,"OperatingExpenses_1_Q3_USD":19868000.0,"NonoperatingIncomeExpense_3_Q3_USD":-1023000.0,"NonoperatingIncomeExpense_1_Q3_USD":31000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":6673000.0,"NetIncomeLoss_3_Q3_USD":-50518000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-98595000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":4360000.0,"TemporaryEquityValueExcludingAdditionalPaidInCapital_0_Q3_USD":0.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":0.0,"TemporaryEquitySharesIssued_0_Q3_shares":0.0,"TemporaryEquitySharesAuthorized_0_Q3_shares":10000000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q3_USD":0.0001,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":30926000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":76950.0,"StockholdersEquity_0_Q3_USD":369305000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":10.14,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":2.19,"ShareBasedCompensation_3_Q3_USD":3344000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":1.66,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":5566421.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":82185000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":7.58,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":5566421.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":82185000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":3812300.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":374309.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":1619000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":4.11,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":239924.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":7.58,"NetIncomeLoss_1_Q3_USD":-19837000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-45191000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-6606000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-51412000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-20372000.0,"CommonStockValue_0_Q3_USD":5000.0,"CommonStockSharesOutstanding_0_Q3_shares":46483918.0,"CommonStockSharesIssued_0_Q3_shares":46780847.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":5863350.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":325900000.0,"DefinedBenefitPensionPlanLiabilitiesNoncurrent_0_Q3_USD":2001000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":368763000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":1909000.0,"AssetsFairValueDisclosure_0_Q3_USD":147862000.0,"AssetsCurrent_0_Q3_USD":370519000.0,"Assets_0_Q3_USD":384049000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":3344000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2073000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":469845000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-1950000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":1896000.0,"AccountsPayableCurrent_0_Q3_USD":3530000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":367034000.0,"DefinedBenefitPlanAdministrationExpenses_1_Q3_USD":132000.0,"DefinedBenefitPlanAdministrationExpenses_3_Q3_USD":319000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q3_USD":89000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":377697000.0,"LiabilitiesCurrent_0_Q3_USD":12743000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":384049000.0,"Liabilities_0_Q3_USD":14744000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":33000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":13000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1593000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":6726000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-5446000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"GeneralAndAdministrativeExpense_3_Q3_USD":10470000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4753000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-13000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-96000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":18000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3_Q3_USD":0.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.85,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.43,"DividendsPayableCurrentAndNoncurrent_0_Q3_USD":0.0,"Depreciation_3_Q3_USD":1323000.0,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_3_Q3_pure":0.04,"DefinedContributionPlanEmployerMatchingContributionPercent_3_Q3_pure":1.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_3_Q3_USD":187000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":45987866.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":17751410.0,"Ticker":"GLUE","CIK":"1826457","name":"MONTE ROSA THERAPEUTICS, INC.","OfficialName":"Monte Rosa Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"606660528.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]